Achyut Healthcare Limited's Board of Directors held a meeting on September 05, 2026, which commenced at 2:00 p.m. and concluded at 2:30 p.m.

The Board discussed and approved the following matters:

  • Approved and took on record the Notice of AGM & Director Report.
  • The Annual General Meeting (AGM) of the Company will be held on September 29, 2026, at 10:30 A.M. through Video Conference (VC) / Other Audio Visual Means (OAVM).
  • Fixed September 22, 2026, as the "Record Date" for determining members eligible to vote on resolutions or attend the AGM.
  • Appointed M/s. Kamlesh M Shah & CO., PCS as Scrutinizers for the e-voting process at the ensuing AGM.

Director Reappointments

The Board considered and approved the reappointment of three directors:

1. Mr. Jigen J. Modi (DIN: 03355555) as Managing Director

  • Reappointment period: From November 01, 2026, to October 31, 2031
  • Remuneration: Up to ₹50,000 per month, payable monthly/quarterly/half-yearly/yearly as per company's financial convenience
  • The Nomination and Remuneration Committee recommended this reappointment
  • Subject to shareholder approval via special resolution under Section 196 of Companies Act 2013 and SEBI (LODR) 2015

2. Mrs. Sonu Lalitkumar Jain (DIN: 09387661) as Non-Executive Independent Director

  • Reappointment period: From November 01, 2026, to October 31, 2031
  • Sitting fees: Up to ₹50,000 per month, payable as per company's financial convenience
  • The Nomination and Remuneration Committee recommended this reappointment
  • Subject to shareholder approval via special resolution under Section 196 of Companies Act 2013 and SEBI (LODR) 2015

3. Mr. Rutvik Sanjaykumar Thakkar (DIN: 09387486) as Non-Executive Independent Director

  • Reappointment period: From November 01, 2026, to October 31, 2031
  • Sitting fees: Up to ₹50,000 per month, payable as per company's financial convenience
  • The Nomination and Remuneration Committee recommended this reappointment
  • Subject to shareholder approval via special resolution under Section 196 of Companies Act 2013 and SEBI (LODR) 2015

Director Details from Annexure

Mr. Jigen J. Modi (Managing Director)

  • Date of Birth: August 25, 1969 (57 years)
  • Nationality: Indian
  • Qualifications: B.COM
  • Experience: Over 25 years in business, marketing & management in pharmaceuticals sector
  • Date of Initial Appointment: November 01, 2021
  • Board Meetings Attended: 8 out of 8
  • Relationship: Husband of Amisha J. Modi, Executive Director of the Company
  • Not debarred from holding director office by SEBI or any authority

Mrs. Sonu Lalitkumar Jain (Independent Director)

  • Date of Birth: July 13, 1996 (30 years)
  • Nationality: Indian
  • Qualifications: Associate Member of ICSI, B.COM from Gujarat University, Bachelor's degree in Law
  • Experience: Over 8 years in securities markets with legal and secretarial practices
  • Date of Initial Appointment: November 01, 2021
  • Remuneration last drawn (2025-26): NIL
  • Equity shares held: Nil
  • Board Meetings Attended: 8 out of 8
  • Other Directorships: JFL Lifescience Limited
  • Committee Memberships: 3 committees (Member) in other companies
  • Relationship: Not related to other directors/KMP
  • Not debarred from holding director office by SEBI or any authority

Mr. Rutvik Sanjaykumar Thakkar (Independent Director)

  • Date of Birth: January 30, 1989 (37 years)
  • Nationality: Indian
  • Qualifications: B.COM & Chartered Accountant
  • Experience: Over 11 years in accounts, audit & finance
  • Date of Initial Appointment: November 01, 2021
  • Remuneration last drawn (2025-26): NIL
  • Equity shares held: NIL
  • Board Meetings Attended: 8 out of 8
  • Other Directorships: Zenith Healthcare Limited
  • Committee Roles: 1 committee (Chairman) and 2 committees (Member) in other companies
  • Relationship: Not related to other directors/KMP
  • Not debarred from holding director office by SEBI or any authority

The disclosure is made pursuant to Secretarial Standard on General Meeting (SS-2) and Regulation 36(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2016.